E-LIB Suche - Ergebnisse für: Langholz, E

1

OC.04.7: A ONE-YEAR FOLLOW-UP STUDY ON CHECKPOINT INHIBITOR..:

Lenti, M.V. ; Broglio, G. ; Ribaldone, D.G....
Digestive and Liver Disease. 56 (2024) - p. S144-S145 , 2024

2

P003 MicroRNAs as biomarkers in Inflammatory Bowel Disease ..:

Pallikkunnath James, J ; Riis, L B ; Malham, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i171-i173 , 2023

Link: https://doi.org/10.1093/..

3

P467 Therapeutic drug monitoring of biologics in Inflammato..:

Bjørlykke, K ; Jahnsen, J ; Brynskov, J...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i441-i441 , 2022

Link: https://doi.org/10.1093/..

4

P029 Expression of miR-21 in mucosal biopsies give clues to..:

Pallikkunnath James, J ; Schnack Nielsen, B ; Langholz, E...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i150-i151 , 2022

Link: https://doi.org/10.1093/..

5

P237 Annual incidence and prevalence of ulcerative colitis ..:

Lördal, M ; Burisch, J ; Langholz, E...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S261-S262 , 2020

Link: https://doi.org/10.1093/..

6

P243 Changes in the therapeutic management of inflammatory ..:

Zhao, M ; Lördal, M ; Langholz, E...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S267-S267 , 2020

Link: https://doi.org/10.1093/..

7

DOP21 Time to first treatment with biologic agents for ulce..:

Høivik, M ; Lördal, M ; Burisch, J...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S060-S061 , 2020

Link: https://doi.org/10.1093/..

8

OP35 Treatment outcomes of inflammatory bowel disease in th..:

Zhao, M ; Lördal, M ; Langholz, E...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S036-S037 , 2020

Link: https://doi.org/10.1093/..

9

P780 Medical treatment and surgery in patients with elderly..:

Hernandez, V ; Martinez-Cadilla, J ; Langholz, E...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S510-S511 , 2019

Link: https://doi.org/10.1093/..

10

OP15 Cost analysis in a prospective European population-bas..:

Burisch, J ; Vardi, H ; Schwartz, D...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S009-S010 , 2019

Link: https://doi.org/10.1093/..

11

DOP019 Immunomodulators reduce the risk of surgery and hosp..:

Burisch, J ; Andersen, V ; Čuković-Čavka, S...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S042-S043 , 2018

Link: https://doi.org/10.1093/..

12

P812 Natural disease course of inflammatory bowel disease u..:

Burisch, J ; Ellul, P ; Arebi, N...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S523-S524 , 2018

Link: https://doi.org/10.1093/..

13

P694 Disease course during the first five years following d..:

Burisch, J. ; Halfvarson, J. ; Kupcinskas, L....
Journal of Crohn's and Colitis. 11 (2017) suppl_1 - p. S435-S436 , 2017

Link: https://doi.org/10.1093/..

14

DOP001 European Crohn's and Colitis Organisation topical re..:

Maaser, C. ; Langholz, E. ; Gordon, H....
Journal of Crohn's and Colitis. 11 (2017) suppl_1 - p. S26-S26 , 2017

Link: https://doi.org/10.1093/..

15

P727 Change in Crohn's disease behavior in a prospective Eu..:

Burisch, J. ; Halfvarson, J. ; Kupcinskas, L....
Journal of Crohn's and Colitis. 11 (2017) suppl_1 - p. S452-S453 , 2017

Link: https://doi.org/10.1093/..